Similar articles for PMID: 24064818

Year	Number of Results
1987	1
1988	1
1991	2
1994	1
1996	1
1997	2
1998	1
1999	1
2000	1
2001	1
2004	1
2005	2
2006	3
2007	2
2008	2
2009	5
2010	6
2011	8
2012	5
2013	6
2014	1
2015	4
2016	1
2017	1
2018	2
2019	3
2020	3
2022	1
2023	1
2024	0

1

[Genomic abnormalities and pathophysiology in myelodysplastic syndrome].

Chiba S. Chiba S. Rinsho Ketsueki. 2013 Oct;54(10):1687-96. Rinsho Ketsueki. 2013. PMID: 24064818 Review. Japanese. No abstract available.

2

[Basic science and pathophysiology of MDS: from a view of its neoplastic aspect and the molecular basis].

Ichikawa M, Kurokawa M. Ichikawa M, et al. Rinsho Ketsueki. 2013 Jan;54(1):5-13. Rinsho Ketsueki. 2013. PMID: 23391642 Review. Japanese. No abstract available.

3

[New insight into myelodysplastic syndromes and related myeloid disorders].

Ogawa S. Ogawa S. Rinsho Ketsueki. 2013 Jun;54(6):533-7. Rinsho Ketsueki. 2013. PMID: 23823091 Review. Japanese. No abstract available.

4

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.

Wang L, Fidler C, Nadig N, Giagounidis A, Della Porta MG, Malcovati L, Killick S, Gattermann N, Aul C, Boultwood J, Wainscoat JS. Wang L, et al. Haematologica. 2008 Jul;93(7):994-1000. doi: 10.3324/haematol.12603. Epub 2008 May 27. Haematologica. 2008. PMID: 18508791 Free article.

5

Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states.

Gondek LP, DeZern AE. Gondek LP, et al. Lancet Haematol. 2020 Jan;7(1):e73-e81. doi: 10.1016/S2352-3026(19)30211-X. Epub 2019 Dec 3. Lancet Haematol. 2020. PMID: 31810765 Free PMC article. Review.

6

Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?

Calvete O, Mestre J, Durmaz A, Gurnari C, Maciejewski JP, Solé F. Calvete O, et al. Br J Haematol. 2023 Apr;201(1):e5-e11. doi: 10.1111/bjh.18676. Epub 2023 Jan 30. Br J Haematol. 2023. PMID: 36717968 No abstract available.

7

Pathophysiology and treatment of the myelodysplastic syndrome with isolated 5q deletion.

Jädersten M. Jädersten M. Haematologica. 2010 Mar;95(3):348-51. doi: 10.3324/haematol.2009.019141. Haematologica. 2010. PMID: 20207839 Free PMC article. No abstract available.

8

Myelodysplastic syndromes.

Tefferi A, Vardiman JW. Tefferi A, et al. N Engl J Med. 2009 Nov 5;361(19):1872-85. doi: 10.1056/NEJMra0902908. N Engl J Med. 2009. PMID: 19890130 Review. No abstract available.

9

Unusual course of myelodysplastic syndrome with presumed familial origin.

Bacher U, Ocheni S, Schafhausen P, Oyekunle A, Dierlamm J, Zander AR, Bokemeyer C, Haferlach T, Kröger N. Bacher U, et al. Acta Haematol. 2011;126(4):234-7. doi: 10.1159/000330529. Epub 2011 Sep 22. Acta Haematol. 2011. PMID: 21952642 No abstract available.

10

Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes.

Padron E, Ball MC, Teer JK, Painter JS, Yoder SJ, Zhang C, Zhang L, Moscinski LC, Rollison DE, Gore SD, Bejar R, Walter MJ, Sekeres MA, Komrokji RS, Epling-Burnette PK. Padron E, et al. Blood. 2018 May 24;131(21):2402-2405. doi: 10.1182/blood-2018-01-827881. Epub 2018 Apr 16. Blood. 2018. PMID: 29661788 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year